Gambaran Hiperplasia Endometrium Pada Kasus Mioma Uteri Di RSUP. H. Adam Malik Medan
41
DAFTAR PUSTAKA
1.
Chethana E, et all. Endometrial changes in uterine meiomyomas. 2013.
Kempegowda Institute of Medical Sciences. J Cin. Biomed Scientifica.
Hal : 72 – 79
2.
Wachidah, et al. Hubungan hiperplasia endometrium dengan mioma
uteri : Studi kasus pada pasien ginekologi RSUD Prof. Dr. Margono
Soekardjo. Mandala of Health. 2011.Vol 5, no.3.
3.
Baziad A. Endokrinologi Ginekologi. Edisi III. Media Aeusculapius FK UI.
Jakarta. 2008. Hal 215 – 222
4.
Witherspoon JT. The hormonal origin of uterine fibroids : an hypotesis.
Tulane university. Amerika Serikat. 1933.
5.
Tim.
Ilmu
Kandungan.
Edisi
II.
PT.
Bina
Pustaka
Sarwono
Prawirohardjo. Jakarta. 2008. Hal : 73 – 90; 338 – 345.
6.
Speroff L, Fritz, MA. Clinical gynecologic endocrinology and infertility.
edisi VII. Lippincott Williams & Wilkins. North Carolina. 2005. Hal : 136 –
140; 561 – 562
7.
Nayak N, et al. Pharmacoepidemiological Study of Uterine Fibroids in
Indore City. International Journal of Pharma and Bio Sciences. 2010.
Vol.1, no.2.
8.
Edward DRV, et al. Association of Age at Menarch with Increasing
Number of Fibroids in a Cohort of Women Who Underwent
Standardized Ultrasound Assessment. Oxford University Press. 2013.
9.
Walker CL, et al. Protektif effect of pegnancy for development of uterine
leiomyoma. Carcinogenesis. Anderson Cancer Center. Smithville. 2001.
vol. 22, no.12. Hal 2049 – 52
10. Davis PC, et all. Sonohysterographic Findings of Endometrial and
Subendometrial Conditions. 2002. Vol. 22, no.4.
42
11. Faerstein E, et al. Risk factors for uterine leiomyoma : A Practice –
based case control study. I. African – American Heritage, Reproductive
History, Body Size, and Smoking. American journal of Epidemiology.
Oxford University Press. 2001. Vol. 153, no.1. Hal 1 – 10.
12. Katz, et al. Katz Comprehensive Gynecology : endometrial hyperplasia.
Edisi 5. Mosby. USA. 2007.
13. Cunningham, et all. Williams gynecology. Edisi I. McGraw-Hill. China.
2008.
14. Gibs RS, et al. Danforth’s Obstetrics and Gynecologic. Edisi X.
Lippincolt Williams and Wilkins. Amerika Serikat. 2008. Hal : 1003 – 6;
917 – 929.
15. DeCherney AH, Nathan L. Current Diagnosis and Treatements in
Obstetrics and Gynecology : Benign Disorders of the Uterine Corpus.
Edisi X. McGraw-Hill. Amerika Serikat. 2007.
16. Lumsden MA. Dewhurts Text book of Obstetrics and Gynaecology :
Benign
disease
of
the
uterus.
Edisi
7.
Blackwell
publishing.
Massachusetts, 2007. hal 636 – 644.
17. Grings AO, et al. Protein Expression of Estrogen Receptors α and β and
Aromatase in Myometrium and Uterine Leiomyoma. 2012. Gynecologic
and Obstetric Investigation. No. 73. Hal 113 – 7
18. Hermon TL, et al. Estrogen receptor alpha (ER-α) phospho-serine-118 is
highly expressed in human uterine leiomyomas compared to mathed
myometrium. 2008. Virchow Arch. No. 453. Hal : 557 - 569
19. Yi Ye, et al. J Assist Reproductive Genetics. CYP1A1 and CYP1B1
genetic polymorphisms and uterine leiomyoma risk in Chinese women.
Springer Science. 2008. Vol. 25.
20. Fortner KB, et all. John Hopkins Manual of Gynecology and Obstetrics.
Edisi III. Lippincott Williams and Wilkins. USA. 2007. Hal 399 – 401; 421
- 422
43
21. Mazur MT, Kurman RJ. Diagnosis of endometrial biopsies and
curretings
:
endometrial
hyperplasia,
endometrial
intraepitheal
carcinoma, and epithelial cytoplasmic change. Edisi 2. Springer.
Amerika serikat. 2005. Hal : 178 – 199.
22. Reed SD, et al. Insidensi of endometrial hyperplasia. Amerika journal
obstetric and gynecology. 2009.
23. Pernoll ML. Benson and Pernoll’s handbook of Obstetric and
Gynecology. Edisi X. McGraw-Hill. Amerika Serikat. 2001. Hal : 619 –
629.
24. Oehler MK, Rees M. The abnormal menstrual cycle : Excessive
menstrual bleeding; Uterine fibroid. Taylor & Francis group. London.
2005. Hal 61 – 70; 79 - 92
25. Childs AJ, et al. Conservative management of endometrial hyperplasia :
new strategies and experimental option. Health University Medical
Center. 2003. Hal : 15 – 26
26. Olive DL, Palter SF. Berek & Novak’s Gynecology. Edisi 14. Lippincott
Williams & Wilkins. California. 2007. Hal : 469 – 471; 1346 – 9.
27. Meniru GI, Hopkins MP. Glass’ office gynecology : abnormal uterine
bleeding. Edisi 6. Lippincott Williams and Wilkins. Amerika serikat. 2006.
hal : 179 – 181
28. Mutter GL. Endometrial precancer : the benign endometrial hyperplasia
squence and EIN. Dept. of pathology brigham and women’s hospital.
Harvard medical school. Boston. 2008.
29. Trimble CL, et al. American college of obstetricians and gynecologists :
Management of endometrial precancers. Vol. 120, no.5. 2012. 1160 –
1172.
30. Hernandez E, Houck KL. Clinical gynecology : Endometrial carcinoma.
Churchill livingstone. Philadelphia. 2006. Hal : 665 – 670.
44
31. Walker JL, Zuna RE. Clinical gynecology oncology : Endometrial
hyperplasia, estrogen therapy, and the prevention of endometrial
cancer. Edisi 7. Mosby Elsevier. Filadelpia. 2007. Hal : 125 – 132.
32. Chu CS. NMS obstetrics and gynecology. Edisi 6. Lippincott Williams
and Wilkins. New York. 2008. Hal : 428 – 429; 259 – 266.
33. Chethana M. Histopathologic Study of Endometrium in Uterine
Leiomyoma. Dept. Of Pathology Sri Devaraj Urs Medical College. Kolar.
2010.
34. Robboy SJ, et al. Environmental Health Perspectives : Pathology and
Pathophysiology of Uterine Smooth-Muscle Tumors. 2000. Vol. 108.
35. Chan CF, et al. Risk factors for uterine fibroids among woman
undergoing tubal sterilization. 2001. A merican Journal of Epidemiology.
Vol. 153. No.1. Hal : 20 – 26
36. Ibrar A, et al. Frequency of fibroid uterus in multipara women in a tertiary
care centre in Rawalpindi. 2010. J Ayub Med Coll Abbottabad. Vol. 22
No. 3. Hal : 155 – 7
37. Lilyani DV, et al. Hubungan faktor risiko dan kejadian mioma uteri di
Rumah Sakit Umum Daerah Tugurejo Semarang. 2012. Jurnal
Kedokteran Muhammadiyah. Vol. 1, No.1. Hal : 14 – 19
38. Terry
KL
et
al.
Anthropometric
Characteristics
and
Risk
of
Uterine Leiomyoma. Epidemiology. 2007. V.18, No.6. Hal : 758
39. Parker
WH.
Etiology,
Symptomatology,
and
Diagnosis
of Uterine Myomas. 2007. Fertility and Sterility. Vol. 87. No.4. Hal : 725
DAFTAR PUSTAKA
1.
Chethana E, et all. Endometrial changes in uterine meiomyomas. 2013.
Kempegowda Institute of Medical Sciences. J Cin. Biomed Scientifica.
Hal : 72 – 79
2.
Wachidah, et al. Hubungan hiperplasia endometrium dengan mioma
uteri : Studi kasus pada pasien ginekologi RSUD Prof. Dr. Margono
Soekardjo. Mandala of Health. 2011.Vol 5, no.3.
3.
Baziad A. Endokrinologi Ginekologi. Edisi III. Media Aeusculapius FK UI.
Jakarta. 2008. Hal 215 – 222
4.
Witherspoon JT. The hormonal origin of uterine fibroids : an hypotesis.
Tulane university. Amerika Serikat. 1933.
5.
Tim.
Ilmu
Kandungan.
Edisi
II.
PT.
Bina
Pustaka
Sarwono
Prawirohardjo. Jakarta. 2008. Hal : 73 – 90; 338 – 345.
6.
Speroff L, Fritz, MA. Clinical gynecologic endocrinology and infertility.
edisi VII. Lippincott Williams & Wilkins. North Carolina. 2005. Hal : 136 –
140; 561 – 562
7.
Nayak N, et al. Pharmacoepidemiological Study of Uterine Fibroids in
Indore City. International Journal of Pharma and Bio Sciences. 2010.
Vol.1, no.2.
8.
Edward DRV, et al. Association of Age at Menarch with Increasing
Number of Fibroids in a Cohort of Women Who Underwent
Standardized Ultrasound Assessment. Oxford University Press. 2013.
9.
Walker CL, et al. Protektif effect of pegnancy for development of uterine
leiomyoma. Carcinogenesis. Anderson Cancer Center. Smithville. 2001.
vol. 22, no.12. Hal 2049 – 52
10. Davis PC, et all. Sonohysterographic Findings of Endometrial and
Subendometrial Conditions. 2002. Vol. 22, no.4.
42
11. Faerstein E, et al. Risk factors for uterine leiomyoma : A Practice –
based case control study. I. African – American Heritage, Reproductive
History, Body Size, and Smoking. American journal of Epidemiology.
Oxford University Press. 2001. Vol. 153, no.1. Hal 1 – 10.
12. Katz, et al. Katz Comprehensive Gynecology : endometrial hyperplasia.
Edisi 5. Mosby. USA. 2007.
13. Cunningham, et all. Williams gynecology. Edisi I. McGraw-Hill. China.
2008.
14. Gibs RS, et al. Danforth’s Obstetrics and Gynecologic. Edisi X.
Lippincolt Williams and Wilkins. Amerika Serikat. 2008. Hal : 1003 – 6;
917 – 929.
15. DeCherney AH, Nathan L. Current Diagnosis and Treatements in
Obstetrics and Gynecology : Benign Disorders of the Uterine Corpus.
Edisi X. McGraw-Hill. Amerika Serikat. 2007.
16. Lumsden MA. Dewhurts Text book of Obstetrics and Gynaecology :
Benign
disease
of
the
uterus.
Edisi
7.
Blackwell
publishing.
Massachusetts, 2007. hal 636 – 644.
17. Grings AO, et al. Protein Expression of Estrogen Receptors α and β and
Aromatase in Myometrium and Uterine Leiomyoma. 2012. Gynecologic
and Obstetric Investigation. No. 73. Hal 113 – 7
18. Hermon TL, et al. Estrogen receptor alpha (ER-α) phospho-serine-118 is
highly expressed in human uterine leiomyomas compared to mathed
myometrium. 2008. Virchow Arch. No. 453. Hal : 557 - 569
19. Yi Ye, et al. J Assist Reproductive Genetics. CYP1A1 and CYP1B1
genetic polymorphisms and uterine leiomyoma risk in Chinese women.
Springer Science. 2008. Vol. 25.
20. Fortner KB, et all. John Hopkins Manual of Gynecology and Obstetrics.
Edisi III. Lippincott Williams and Wilkins. USA. 2007. Hal 399 – 401; 421
- 422
43
21. Mazur MT, Kurman RJ. Diagnosis of endometrial biopsies and
curretings
:
endometrial
hyperplasia,
endometrial
intraepitheal
carcinoma, and epithelial cytoplasmic change. Edisi 2. Springer.
Amerika serikat. 2005. Hal : 178 – 199.
22. Reed SD, et al. Insidensi of endometrial hyperplasia. Amerika journal
obstetric and gynecology. 2009.
23. Pernoll ML. Benson and Pernoll’s handbook of Obstetric and
Gynecology. Edisi X. McGraw-Hill. Amerika Serikat. 2001. Hal : 619 –
629.
24. Oehler MK, Rees M. The abnormal menstrual cycle : Excessive
menstrual bleeding; Uterine fibroid. Taylor & Francis group. London.
2005. Hal 61 – 70; 79 - 92
25. Childs AJ, et al. Conservative management of endometrial hyperplasia :
new strategies and experimental option. Health University Medical
Center. 2003. Hal : 15 – 26
26. Olive DL, Palter SF. Berek & Novak’s Gynecology. Edisi 14. Lippincott
Williams & Wilkins. California. 2007. Hal : 469 – 471; 1346 – 9.
27. Meniru GI, Hopkins MP. Glass’ office gynecology : abnormal uterine
bleeding. Edisi 6. Lippincott Williams and Wilkins. Amerika serikat. 2006.
hal : 179 – 181
28. Mutter GL. Endometrial precancer : the benign endometrial hyperplasia
squence and EIN. Dept. of pathology brigham and women’s hospital.
Harvard medical school. Boston. 2008.
29. Trimble CL, et al. American college of obstetricians and gynecologists :
Management of endometrial precancers. Vol. 120, no.5. 2012. 1160 –
1172.
30. Hernandez E, Houck KL. Clinical gynecology : Endometrial carcinoma.
Churchill livingstone. Philadelphia. 2006. Hal : 665 – 670.
44
31. Walker JL, Zuna RE. Clinical gynecology oncology : Endometrial
hyperplasia, estrogen therapy, and the prevention of endometrial
cancer. Edisi 7. Mosby Elsevier. Filadelpia. 2007. Hal : 125 – 132.
32. Chu CS. NMS obstetrics and gynecology. Edisi 6. Lippincott Williams
and Wilkins. New York. 2008. Hal : 428 – 429; 259 – 266.
33. Chethana M. Histopathologic Study of Endometrium in Uterine
Leiomyoma. Dept. Of Pathology Sri Devaraj Urs Medical College. Kolar.
2010.
34. Robboy SJ, et al. Environmental Health Perspectives : Pathology and
Pathophysiology of Uterine Smooth-Muscle Tumors. 2000. Vol. 108.
35. Chan CF, et al. Risk factors for uterine fibroids among woman
undergoing tubal sterilization. 2001. A merican Journal of Epidemiology.
Vol. 153. No.1. Hal : 20 – 26
36. Ibrar A, et al. Frequency of fibroid uterus in multipara women in a tertiary
care centre in Rawalpindi. 2010. J Ayub Med Coll Abbottabad. Vol. 22
No. 3. Hal : 155 – 7
37. Lilyani DV, et al. Hubungan faktor risiko dan kejadian mioma uteri di
Rumah Sakit Umum Daerah Tugurejo Semarang. 2012. Jurnal
Kedokteran Muhammadiyah. Vol. 1, No.1. Hal : 14 – 19
38. Terry
KL
et
al.
Anthropometric
Characteristics
and
Risk
of
Uterine Leiomyoma. Epidemiology. 2007. V.18, No.6. Hal : 758
39. Parker
WH.
Etiology,
Symptomatology,
and
Diagnosis
of Uterine Myomas. 2007. Fertility and Sterility. Vol. 87. No.4. Hal : 725